Live Breaking News & Updates on James Millen

Stay updated with breaking news from James millen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Investegate |Physiomics PLC Announcements | Physiomics PLC: Issue of Options


 
Physiomics plc (AIM: PYC) is an oncology consultancy using mathematical models to support the development of cancer treatment regimens and personalised medicine solutions. The Company s Virtual Tumour™ technology uses computer modelling to predict the effects of cancer drugs and treatments to improve the success rate of drug discovery and development projects while reducing time and cost. The predictive capability of Physiomics technologies have been confirmed by over 80 projects, involving over 40 targets and 70 drugs, and has worked with clients such as Merck KGaA, Astellas, Merck & Co and Bicycle Therapeutics.
 
 
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please co ....

City Of , United Kingdom , James Bellman , Paul Harper , Jim Millen , Christophe Chassagnole , James Millen , Company Ordinary , Strand Hanson Ltd , Merck Kga , Company Non , Company Virtual Tumour , Merck Kgaa , Merck Co , Non Employee Share Option Scheme , Ordinary Shares , Ordinary Share , Hanson Ltd , Market Abuse Regulation , Virtual Tumour , Investegate Announcements , Investegate Company Announcements , Physiomics Plc , Regulatory News Service , Regulatory News Service And , நகரம் ஆஃப் ,